A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia
Open Access
- 6 July 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (31) , 49777-49785
Abstract
A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemiaKeywords
This publication has 25 references indexed in Scilit:
- Mitochondrial glutathione: Features, regulation and role in diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid LeukemiaCancer Cell, 2011
- Targeting the Mitochondria Activates Two Independent Cell Death Pathways in Ovarian Cancer Stem CellsMolecular Cancer Therapeutics, 2011
- Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+‐induced neurodegenerationJournal of Neurochemistry, 2010
- Mitochondrial Glutathione, a Key Survival AntioxidantAntioxidants & Redox Signaling, 2009
- NV‐128, a novel isoflavone derivative, induces caspase‐independent cell death through the Akt/mammalian target of rapamycin pathwayCancer, 2009
- Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugsExpert Opinion on Pharmacotherapy, 2009
- Glaziovianin A, a new isoflavone, from the leaves of Ateleia glazioviana and its cytotoxic activity against human cancer cellsBioorganic & Medicinal Chemistry Letters, 2007
- Microtubules as a target for anticancer drugsNature Reviews Cancer, 2004